Literature DB >> 29343199

CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.

Byung-Joon Seung1, Ha-Young Lim1, Jong-Il Shin1, Hyun-Woo Kim1, Seung-Hee Cho1, Soo-Hyeon Kim1, Jung-Hyang Sur1.   

Abstract

Tumor-associated macrophages (TAMs) are an important component of leukocyte infiltration in tumors. TAMs can be classified into M1 and M2 phenotypes. In the present study, the expression of CD204, an M2-polarized macrophage receptor, was investigated by immunohistochemistry in the area surrounding TAMs in 101 cases of canine mammary gland tumor (CMT). We examined the relationship between M2-polarized TAMs and malignancy, histological subtype, histological grade, molecular subtype, hormone receptor (HR) status, and clinical obesity indices. The mean number of CD204-positive macrophages was significantly higher in malignant CMTs than in benign CMTs ( P = .000). The number of CD204-positive macrophages differed significantly between histological grades ( P = .000) and were significantly higher in grade III than in grades I and II. Moreover, the mean number of CD204-positive macrophages was significantly higher in HR-negative malignant CMTs than in HR-positive malignant CMTs ( P = .035) and in malignant CMTs with lymphatic invasion compared to malignant CMTs without lymphatic invasion ( P = .000). These findings suggest that CD204-positive macrophages might affect the development and behavior of CMTs and highlight the potential of CD204 as a prognostic factor.

Entities:  

Keywords:  CD204; M2-polarized macrophage; canine; mammary gland tumor; tumor-associated macrophage

Mesh:

Substances:

Year:  2018        PMID: 29343199     DOI: 10.1177/0300985817750457

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  6 in total

1.  Inhibition of circRNA circVPS33B Reduces Warburg Effect and Tumor Growth Through Regulating the miR-873-5p/HNRNPK Axis in Infiltrative Gastric Cancer.

Authors:  Yizhuo Lu; Jia Cheng; Wangyu Cai; Huiqin Zhuo; Guoyang Wu; Jianchun Cai
Journal:  Onco Targets Ther       Date:  2021-05-12       Impact factor: 4.147

Review 2.  Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.

Authors:  Enni Markkanen
Journal:  Front Cell Dev Biol       Date:  2019-12-17

3.  Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis.

Authors:  Byung-Joon Seung; Seung-Hee Cho; Soo-Hyeon Kim; Ha-Young Lim; Jung-Hyang Sur
Journal:  PLoS One       Date:  2020-02-14       Impact factor: 3.240

Review 4.  Canine Cancer: Strategies in Experimental Therapeutics.

Authors:  Douglas H Thamm
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

5.  Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.

Authors:  Yunjie He; Siying Zhou; Fei Deng; Shujie Zhao; Wenquan Chen; Dandan Wang; Xiu Chen; Juncheng Hou; Jian Zhang; Wei Zhang; Li Ding; Jinhai Tang; Zuomin Zhou
Journal:  Aging (Albany NY)       Date:  2019-12-04       Impact factor: 5.682

6.  The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications.

Authors:  Catarina Nascimento; Andreia Gameiro; Jorge Correia; João Ferreira; Fernando Ferreira
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.